Your browser doesn't support javascript.
loading
AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2.
Chibwana, Marah G; Moyo-Gwete, Thandeka; Kwatra, Gaurav; Mandolo, Jonathan; Hermanaus, Tandile; Motlou, Thopisang; Mzindle, Nonkululeko; Ayres, Frances; Chaponda, Mphatso; Tembo, Godwin; Mwenechanya, Percy; Mitole, Ndaona; Jassi, Chisomo; Kamng'ona, Raphael; Afran, Louise; Mzinza, David; Mwandumba, Henry C; Gordon, Stephen B; Jere, Khuzwayo; Madhi, Shabir; Moore, Penny L; Heyderman, Robert S; Jambo, Kondwani C.
Afiliação
  • Chibwana MG; Malawi-Liverpool-Wellcome Trust Clinical Research programme (MLW), Blantyre, Malawi.
  • Moyo-Gwete T; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Kwatra G; MRC Antibody Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Mandolo J; Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Hermanaus T; Department of Science/ National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Faculty of Health Science, Johannesburg, South Africa.
  • Motlou T; Department of Clinical Microbiology, Christian Medical College, Vellore, India.
  • Mzindle N; Malawi-Liverpool-Wellcome Trust Clinical Research programme (MLW), Blantyre, Malawi.
  • Ayres F; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Chaponda M; MRC Antibody Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Tembo G; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Mwenechanya P; MRC Antibody Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Mitole N; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Jassi C; MRC Antibody Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Kamng'ona R; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Afran L; MRC Antibody Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Mzinza D; Malawi-Liverpool-Wellcome Trust Clinical Research programme (MLW), Blantyre, Malawi.
  • Mwandumba HC; Malawi-Liverpool-Wellcome Trust Clinical Research programme (MLW), Blantyre, Malawi.
  • Gordon SB; Malawi-Liverpool-Wellcome Trust Clinical Research programme (MLW), Blantyre, Malawi.
  • Jere K; Malawi-Liverpool-Wellcome Trust Clinical Research programme (MLW), Blantyre, Malawi.
  • Madhi S; Malawi-Liverpool-Wellcome Trust Clinical Research programme (MLW), Blantyre, Malawi.
  • Moore PL; Malawi-Liverpool-Wellcome Trust Clinical Research programme (MLW), Blantyre, Malawi.
  • Heyderman RS; Malawi-Liverpool-Wellcome Trust Clinical Research programme (MLW), Blantyre, Malawi.
  • Jambo KC; Malawi-Liverpool-Wellcome Trust Clinical Research programme (MLW), Blantyre, Malawi.
BMC Med ; 20(1): 128, 2022 03 28.
Article em En | MEDLINE | ID: mdl-35346184

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Malauí

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Malauí